Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Whitney Tilson Says More Confident of Herbalife Short Position Following Ackman Presentation

Courtesy of Benzinga.

Whitney Tilson said in an email Tuesday, that he is more confident in his short position in Herbalife (NYSE: HLF), following Bill Ackman’s presentation. Tilson said he now believes his position has a 76% chance of succeeding vs 63% prior. That’s based on his belief that there is a 95% chance most of the company’s operations are a pyramid scheme, and there is now an 80% chance regulators will intervene.

Herbalife shares rose steadily throughout Ackman’s presentation Tuesday, and end the day up 25% at $77.67

Posted-In: News Movers & Shakers Insider Trades General





Benzinga’s M&A Chatter for Thursday July 10, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday July 10, 2014:

ZF Friedrichshafen Confirms in Talks to Buy TRW Automotive

The Offer:
Shares of TRW Automotive (NYSE: TRW) soared Thursday, on a report from Bloomberg that the company could be acquired for as much as $12 billion by Germany’s ZF Friedrichshafen AG.

TRW later confirmed it had been approached by a potential buyer, followed by Friedrichshafen confirming it was in talks to acquire TRW. Shares of TRW were first halted on a circuit-breaker following the Bloomberg report, eventually hitting a high of $101.98, and then prior to the TRW announcement.

TRW Automotive shares closed off the highs Thursday at $98.91, a gain of more than 8%.

Report PE Firms Have Renewed Interest in Symantec

The Rumor:
Shares of Symantec (NYSE: GME) spiked higher Thursday, on a report from Deal Reporter that the company was in takeover talks with private equity firms, including CVC, Carlyle and Bain. Symantec shareholder Valueact reported a new stake of 7.59 million shares on May 14 and has been seeking changes in the company.

Symantec shares closed Thursday at $22.83, a gain of $0.20.

Crumbs Shares Skyrocket 1200% on Potential Investment

The Investment:
Shares of failed cupcake bakery chain Crumbs (OTC: CRMB) rose 1200% Thursday, hitting a high of $0.55, after closing at just $0.03 on Wednesday, on a report from CNBC that the company was close to securing financing from a group including Marcus Lemonis of CNBC’s “The Profit”. Lemonis plans to move other holdings, including Sweet Pete’s into Crumbs. One of he issues causing problems for Crumbs, was its narrow assortment of product, according to CEO Ed Slezak.

Crumbs announced the closing of its stores on July 7, following its shares being delisted from the Nasdaq on July 1.

Crumbs closed Thursday at $0.40, a gain of $0.37.

Posted-In: News Rumors Management Insider Trades M&A Movers





Benzinga’s M&A Chatter for Wednesday July 9, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 9, 2014:

Google Rumored to Have Interest in Deal for Time Warner

The Rumor:
Shares of Time Warner (NYSE: TWX) surged higher Tuesday, following a tweet from Fox Business’ Charlie Gasparino, that he has been hearing chatter of a potential bid from Google (NASDAQ: GOOG). Time Warner shares hit a high of $73.07.

Wall Street Journal reporter Doug MacMillan later tweeted that Time Warner’s CEO said his company was not in talks with Google.

Time Warner shares closed off the highs Wednesday at $72.41, a gain of more than 2%.

Hearing Potential Bid for GameStop

The Rumor:
Shares of GameStop (NYSE: GME) spiked higher Wednesday, on renewed unconfirmed market chatter of a potential bid from an unnamed suitor. Chatter had surfaced on June 22 that GameStop had hired an advisor to help it to review strategic alternatives.

A spokesperson for GameStop was unavailable for comment.

GameStop shares closed Wednesday at $41.79, a gain of $0.15.

AbbVie Forced to Retract Comments Regarding Shire Takeover Attempt

The Withdrawn Comments:
AbbVie (NYSE: ABBV) CEO Richard Gonzalez was forced to withdraw comments he made regarding shareholder support for his company’s bid for Shire (NASDAQ: SHPG). The comments were a violation of UK Takeover Panel rules, as the support was not in writing.

AbbVie confirmed today, it had not received commitments of support in writing.

Shire closed Wednesday at $235.08, a gain of almost 1%, while AbbVie lost more than 1% to close at $55.01.

Shareholders Urge Allergan to Make Acquisitions

The CEO Comments:
Allergan (NYSE: AGN) shareholders are encouraging the company to make a large acquisition in order to fight off a $53 billion hostile takeover bid from Valeant Pharmaceuticals (NYSE: VRX) and investor Bill Ackman of Pershing Square, according to a report from Financial Times. Allergan CEO David Pyott, said his company should act quickly in making an acquisition, based on comments from shareholders.

Allergan’s board rejected Valeant’s latest bid of $53 billion in cash and Valeant shares on June 23.

Allergan closed Wednesday at $165.20, a loss of $0.87, while Valeant lost 1% to close at $120.94.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades Movers General





Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

Courtesy of Benzinga.

Related ARNA
Benzinga's Top #PreMarket Losers
Markets Marginally Lower Ahead Of Earnings Season

Arena Pharmaceuticals (NASDAQ: ARNA) shares plunged Monday on news that its chief executive Jack Lief sold nearly 40 percent of his holdings in the company.

Lief sold 223,525 shares on July 1 at $5.85 per share. The transaction was an "automatic sell" apparently triggered by a declining share price.

While unusual, the transaction isn't unique among Arena's insider deals. Dominick Behan sold 200,000 shares at $6.30 per share in October, according to filings.

"Lief dumping 40% of his Arena shares all at once when the stock is hitting new lows isn't exactly confidence inspiring," wrote TheStreet columnist Adam Feuerstein.

Feuerstein said the transaction is the death knell of intermittent rumors that Eisai Co. (OTC: ESALY) will acquire Arena.

After opening sharply lower Monday, Arena traded recently at $5.33, down 8.73 percent.

Posted-In: News Insider Trades Movers





American Apparel, Phillips 66 And Others Insiders Have Been Buying

Courtesy of Benzinga.

Related AAP
O'Reilly Automotive Tops Q2 Earnings on Operational Merit
Worst Performing Industries For July 22, 2014

American Apparel, Consolidated Edison and Phillips 66 are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it.

Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares.

Accelerate Diagnostics

Recently, one director and one beneficial owner have picked up more than 38,000 Accelerate Diagnostics (NASDAQ: AXDX) shares combined for a total price of almost $1 million. Note that the same beneficial owner also bought $5 million worth of shares back in May.

This Arizona-based medical research company has a market cap of a little over $1 billion and a return on equity that is in the red. Short interest is more than 10 percent of the total float. Shares have pulled back more than 12 percent from a recent 52-week high. Over the past six months, the stock has outperformed the S&P 500.

American Apparel

Ousted CEO Dov Charney recently scooped up more than 27.3 million shares of American Apparel (NYSE: AAP) as part of his attempt to get the company back. That was worth more than $19.5 million. Hedge fund Standard General is helping Charney, and also bought about 1.5 million shares since.

The market cap is about $9.8 billion. The return on equity is more than 100 percent, but the operating margin is in the red. The share price has swung wildly since Charney's ouster, and over the past six months, the stock has underperformed the likes of Abercrombie & Fitch and Urban Outfitters.

See also: American Apparel Imperiled By Lender's Repayment Demand

Consolidated Edison

A number of executives,…
continue reading





Benzinga’s Weekend M&A Chatter

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 27 through Sunday June 29, 2014:

Tencent Acquires Approximately 20% Stake in 58.com for $736M

The Deal:
58.com (NYSE: WUBA) and Tencent Holdings (OTC: TCEHY) announced Friday that Tencent has agreed to invest $736 million in exchange for approximately 19.9% equity interest in 58.com. Under the agreement, Tencent is purchasing 36.805M Class A and B ordinary shares at $20 per share, or $40 per ADS. 58.com will use part of the proceeds from this transaction to buyback 27,603 million shares from existing pre-IPO shareholders.

58.com closed Friday at $54.90, a gain of 5%.

Rackspace Shares Fall on Reported Lack of Takeover Interest

The Rumor:
Shares of Rackspace (NYSE: RAX) fell sharply Friday, on a report from Deal Reporter that there has been a lack of interest from potential buyers for the web hosting company, due to cash flow issues. Rackspace has been the subject of frequent takeover chatter, with IBM (NYSE: IBM) being often mentioned as a potential suitor.

Rackspace closed Friday at $33.63, a loss of more than 7%.

Pershing Square Settles Poison Pill Litigation

The Settlement:
Bill Ackman’s Pershing Square Capital Management announced Friday, it has reached a settlement with Allergan (NYSE: AGN), resolving the previously announced poison pill litigation before the Delaware Court of Chancery.

The settlement provides that Pershing Square’s solicitation and receipt of revocable proxies to call a special meeting of shareholders of Allergan will not trigger the poison pill, and paves the way for Pershing Square to begin actively soliciting proxies to call the special meeting.

Allergan has rejected Valent Pharmaceutical’s takeover bids, the current offer being $53 billion in cash and Valeant shares. The rejections have prompted Ackman and Valeant to present the offer directly to Allergan shareholders.

Allergan closed Friday at $173.95, a gain of 2%, while Valeant closed at $128.85, a gain of almost 2%.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades M&A General





Benzinga’s M&A Chatter for Monday July 28, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday July 28, 2014:

Dollar Tree to Acquire Family Dollar Stores for $74.50/Share in Cash, Stock Deal

The Deal:
Dollar Tree (NASDAQ: DLTR) and Family Dollar Stores (NYSE: FDO) announced Monday that they have entered into a definitive merger agreement, under which Dollar Tree will acquire Family Dollar in a cash and stock deal, valued $74.50 per share. Under the terms of the agreement, Family Dollar shareholders will receive $59.60 in cash and $14.90 in Dollar Tree shares.

The deal is expected to close in early 2015.

Family Dollar shares closed Monday at $75.74, a gain of 25%. Dollar Tree shares rose more than 1% to close at $54.87.

Zillow to Acquire Trulia for $3.5B in Stock

The Deal:
Zillow (NASDAQ: Z) announced Monday that it has agreed to acquire Trulia (NYSE: TRLA) for $3.5 billion in an all-stock transaction. The Boards of Directors of both companies have approved the deal, expected to close in 2015.

Trulia shares closed Monday at $65.04, a gain of 15%, while Zillow shares rose almost 1% to close at $160.32.

Report Apple to Acquire Radio App Swell for $30M

The Rumor:
Apple is near a deal for talk-radio app Swell, according to Re/Code.
The deal is valued at around $30 million, according to sources.

Apple did not immediately confirm the deal.

Apple shares closed Monday at $99.02, a gain of almost 1.5%

Retrophin Offers to Acquire Clinuvel Pharmaceuticals for $2.17/Share

The Offer:
Retrophin (NASDAQ: RTRX) announced Monday, that on July 17, 2014 it submitted an offer to Clinuvel Pharmaceuticals (OTC: CLVLY) Board of Directors, to acquire all of the shares of Clinuvel stock that Retrophin does not own for 0.175 Retrophin shares per Clinuvel share, or A$2.17 per share in cash. Retrophin currently owns approximately 4.88% of Clinuvel shares.

Retrophin shares closed Monday at $10.86, a loss of 5.5%.

Pilgrim’s Pride to Acquire Tyson Foods Mexican Poultry Business in $400M Transaction

The Deal:
Pilgrim’s Pride (NYSE: PPC) announced Monday that it will acquire the poultry businesses of Tyson Foods (NYSE: TSN) in Mexico, in a deal valued at $400 million in cash. Pilgrim’s Pride, is majority owned by JBS USA Holdings.

Tyson Foods shares closed Monday at $40.56, a gain of 2.5%.

Posted-In: News Rumors M&A Movers





Report: Tesla Signs Panasonic Battery Joint Venture Pact

Courtesy of Benzinga.

Related TSLA
Markets Little Changed Ahead Of The Federal Reserve's Policy Decision
Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More
The Connected Car: Do Consumers Care? (Fox Business)

Tesla Motors (NASDAQ: TSLA) inked a joint venture agreement with Panasonic (OTC: PCRFY) for Tesla's so-called Gigafactory in the U.S., according to a Japanese new service.

Tesla traded recently at $228.72, up 2.3 percent.

Nikkei Asian Review reported Monday that Panasonic will initially invest $194 million to $291 million, with the amount to rise eventually to as much as $1 billion with the total cost of the factory to reach as much as $5 billion.

Related Link: Toyota's New Fuel Cell Car Does Not Impress Tesla's Elon Musk

An announcement of the deal will be made by the end of July, the news service said, although it cited no sources.

Tesla CEO Elon Musk has previously said Panasonic would be a logical partner for the project, but his Panasonic counterpart Kazuhiro Tsuga has reportedly been hesitant.

Panasonic acquired a two percent stake in Tesla in 2010 and has made batteries for the company since 2011. Panasonic agreed in October to provide two billion batteries to Tesla by 2017.

Tesla is expected to begin construction this year, with production expected by 2017. The long-term aim is to provide batteries for 500,000 cars annually by 2020.

Posted-In: Gigafactory PanasonicNews Rumors Hot





Deja Vu? TV Reporter Repeats His Tweet: USANA Falls 2%

Courtesy of Benzinga.

Related USNA
USANA Down 5% After Short Seller, Greenberg Separately Offer Negative News
Herbalife Expands Product Line – Analyst Blog

Related HLF
Ackman Beats Icahn On Herbalife's Q2 Earnings
Is Herbalife (HLF) Poised to Beat Earnings Estimates?
Every Leader's Achilles Heel (Fox Business)

USANA Health Sciences< (NYSE: USNA) fell more than two percent Monday day after CNBC reporter Herb Greenberg once again suggested in a tweet the company faces unwanted scrutiny in China.

Greenberg’s tweet was almost identical to one he posted two weeks ago, when said the company is the topic of an “investigation” by a Chinese business publication. USANA shares fell five percent.

On Monday, shares of the Utah-based multi-level marketer were down $1.91 to $70.24.

Greenberg’s latest tweet on the company Monday said it’s is now the the topic of a follow-up article. As previously, Greenberg provided a link to a Chinese-language Web site which he did not purport to translate.

The earlier tweet almost immediately followed a report posted by short-seller Andrew Left saying that “this week multiple media outlets in China have exposed the multi-level marketing schemes operated by USANA.”

Left’s CitronResearch site was silent on USANA Monday.

Both Left and Greenberg have previously offered negative reports on USANA. The multi-level marketing company that provides nutritional supplements has also been the target of short sellers in the past.

Short interest currently accounts for about 1.55 million of USANA’s 13.9 million shares outstanding. That’s down from 1.6 million shares June 30.

Multi-level marketing has recently proven controversial.

Last week, short-seller Bill Ackman promised to deliver a “death blow” to the similar Herbalife Ltd. (NYSE: HLF) in a conference speech.

In a widely published letter last month, Bill Keep, business dean of the College of New Jersey, asked the Securities and Exchange Commission to undertake an ongoing review of multilevel marketing. Keep’s letter refered broadly to the industry and specifically to Herbalife.

USANA traded down 2.4 percent Monday’s morning session to $70.24 a share; Herbalife, slated to report earnings later Monday, was down 0.5 percent to $66.41.

Posted-In: Herb GreenbergNews Rumors





Report Amazon to Launch Credit Card Reader

Courtesy of Benzinga.

Amazon (NASDAQ: AMZN) could be launching its own mobile credit card reader, to compete against those from Square and Ebay’s (NASDAQ: EBAY) PayPal, according to a report from 9to5Mac. The Amazon Card Reader reportedly will sell for $9.99 and will be available at Staples (NASDAQ: SPLS), according to internal documents.

View article http://9to5mac.com/2014/07/27/amazon-apparently-set-to-launch-square-com…

Posted-In: 9TO5MacNews Rumors Tech





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Phil's Favorites

Housing Prices Did NOT Decline In May as Case Shiller Reported and Are Still Running Hot

Housing Prices Did NOT Decline In May as Case Shiller Reported and Are Still Running Hot

Courtesy of Lee Adler 

I won’t go into the specifics of the worst housing indicator in the world, released today and dutifully spewed by the world’s mainstream financial infomercial outlets. If you want to pick through that type of garbage, go read the Wall Street Journal or Bloomberg or watch CNBC. You can get the irrelevant and misleading data on US housing prices there.

Presented as a public service, here’s a review of a several housing price indicators which are timely and are not smoothed and lagged to the...



more from Ilene

Zero Hedge

Why China Couldn't Care Less About Its Stock Market

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Following the latest liquidity injections by the PBOC (set to make 2014 the biggest credit creation year since Lehman), countless bailouts of insolvent companies by Beijing and local governments despite promises there would be no bailouts, and what some have dubbed is an actual Chinese QE, all making it quite clear that China was clearly not serious when it threatened to burst the housing bubble (it hoped it could do a "controlled landing"; it failed which means full steam ahead onto the inevitable NPL collapse), Chinese stocks ...



more from Tyler

Chart School

Consumer Confidence Surges; Highest Since the 2007 Market Peak

Courtesy of Doug Short.

The Latest Conference Board Consumer Confidence Index was released this morning based on data collected through July 17. The headline number of 90.9 was an improvement over the revised June final reading of 86.4, an upward revision from 85.2. Today's number dramatically beat the Investing.com forecast of 85.3. The current level is the highest since October 2007, the month the S&P 500 peaked prior to the Great Recession.

Here is an excerpt from the Conference Board press release.

Says Lynn Franco, Director of Economic Indicators at The Conference Board: “Consumer confidence increased for the third consecutive month and is now at its highest level since October 2007 (95.2). Strong j...

more from Chart School

Insider Scoop

Report: IBM Rejects Offer For Chip Operations

Courtesy of Benzinga.

Related IBM Blackberry Attempts To Rebound From IBM/Apple Deal The 10 Most-Respected Corporate Brands Can the iRally Endure? (Fox Business)

International Business Machines (NYSE: IBM) rejected an offer for part of its semiconductor manufacturing operations, according to unnamed sources cited by ...



http://www.insidercow.com/ more from Insider

Option Review

Kellogg Call Options Active Ahead Of Earnings

Shares in packaged foods producer Kellogg Co. (Ticker: K) are in positive territory on Monday afternoon, trading up by roughly 0.20% at $65.48 as of 2:20 p.m. ET. Options volume on the stock is well above average levels today, with around 12,500 contracts traded on the name versus an average daily reading of around 1,700 contracts. Most of the volume is concentrated in September expiry calls, perhaps ahead of the company’s second-quarter earnings report set for release ahead of the opening bell on Thursday. Time and sales data suggests traders are snapping up calls at the Sep 67.5, 70.0 and 72.5 strikes. Volume is heaviest in the Sep 72.5 strike calls, with around 4,600 contracts traded against sizable open interest of approximately 11,800 contracts. It looks like traders paid an average premium of $0.37 per contrac...



more from Caitlin

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Sabrient

Sector Detector: Bold bulls dare meek bears to take another crack

Courtesy of Sabrient Systems and Gradient Analytics

Once again, stocks have shown some inkling of weakness. But every other time for almost three years running, the bears have failed to pile on and get a real correction in gear. Will this time be different? Bulls are almost daring them to try it, putting forth their best Dirty Harry impression: “Go ahead, make my day.” Despite weak or neutral charts and moderately bullish (at best) sector rankings, the trend is definitely on the side of the bulls, not to mention the bears’ neurotic skittishness about emerging into the sunlight.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then offer up some actionable trading ideas, incl...



more from Sabrient

OpTrader

Swing trading portfolio - week of July 28th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW in the comments below each post. 

Our weekly newsletter Stock World Weekly is ready for your enjoyment.

Read about the week ahead, trade ideas from Phil, and more. Please click here and sign in with your PSW user name and password. Or take a free trial.

We appreciate your feedback--please let us know what you think in the comment section below.  

...

more from SWW

Digital Currencies

BitLicense Part 1 - Can Poorly Thought Out Regulation Drive the US Economy Back into the Dark Ages?

Courtesy of Reggie Middleton.

An Op-Ed piece penned by Veritaseum Chief Contracts Officer, Matt Bogosian

This past weekend (despite American Airlines' best efforts), Reggie and I made it to the Second Annual North American Bitcoin Conference in Chicago. While there were some very creative (and very ambitious) ideas on how to try to realize the disruptive Bitcoin protocol, one of the predominant topics of discussion was New York Superintendent of Financial Services Benjamin Lawsky's proposed Bitcoin regulations (the BitLicense proposal) - percieved by many participants at the event as an apparent ...



more from Bitcoin

Market Shadows

Danger: Falling Prices

Danger: Falling Prices

By Dr. Paul Price of Market Shadows

 

We tried holding up stock prices but couldn’t get the job done. Market Shadows’ Virtual Value Portfolio dipped by 2% during the week but still holds on to a market-beating 8.45% gain YTD. There was no escaping the downdraft after a major Portuguese bank failed. Of all the triggers for a large selloff, I’d guess the Portuguese bank failure was pretty far down most people's list of "things to worry about." 

All three major indices gave up some ground with the Nasdaq composite taking the hardest hi...



more from Paul

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>